Introduction.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 30156444.
- Also identified by DOI 10.18553/jmcp.2018.24.9-a.s3 and PMC identifier 10408403.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This supplement was funded by Novo Nordisk. McGill has received grants and personal fees from Novo Nordisk; grants from AstraZeneca, Novartis, Lexicon, and Pfizer; and personal fees from Intarcia, Boehringer-Ingelheim, Janssen, Mannkind, Bayer, and Merck.
Medical subject headings
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents